We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+6.96%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$4.16B
AUM Growth
+$312M
Cap. Flow
+$49.6M
Cap. Flow %
1.19%
Top 10 Hldgs %
18.39%
Holding
702
New
49
Increased
376
Reduced
176
Closed
46

Top Buys

Rank Stock Value
1
CNI icon
Canadian National Railway
CNI
+$30.2M
2
ABBV icon
AbbVie
ABBV
+$24.4M
3
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$23.7M
4
JNPR
Juniper Networks
JNPR
+$23M
5
TXN icon
Texas Instruments
TXN
+$21.2M

Top Sells

Rank Stock Value
1
PG icon
Procter & Gamble
PG
+$26.9M
2
YHOO
Yahoo Inc
YHOO
+$20.9M
3
EMC
EMC CORPORATION
EMC
+$19.1M
4
CBRE icon
CBRE Group
CBRE
+$15.9M
5
INTC icon
Intel
INTC
+$15.8M

Sector Composition

Rank Sector Weight
1 Healthcare 25.52%
2 Financials 12.75%
3 Technology 11.83%
4 Communication Services 9.9%
5 Consumer Staples 8.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SO icon
301
Southern Company
SO
$110B
$2.47M 0.06%
48,178
+12,306
+34% +$648K
TU icon
302
Telus
TU
$16B
$2.44M 0.06%
148,200
-4,710
-3% -$77.8K
CTMX icon
303
CytomX Therapeutics
CTMX
$705M
$2.43M 0.06%
155,000
+88,000
+131% +$1.06M
AEP icon
304
American Electric Power
AEP
$73.7B
$2.42M 0.06%
37,710
+6,665
+21% +$448K
TRP icon
305
TC Energy
TRP
$73.5B
$2.42M 0.06%
50,991
-3,953
-7% -$185K
TECH icon
306
Bio-Techne
TECH
$11.2B
$2.41M 0.06%
88,000
-8,000
-8% -$220K
ININ
307
DELISTED
Interactive Intelligence Group, inc.
ININ
$2.41M 0.06%
+40,000
New +$2.16M
JUNO
308
DELISTED
Juno Therapeutics, Inc.
JUNO
$2.4M 0.06%
+80,000
New +$2.49M
PXD
309
DELISTED
Pioneer Natural Resource Co.
PXD
$2.38M 0.06%
12,810
+4,860
+61% +$827K
PAYX icon
310
Paychex
PAYX
$40.4B
$2.38M 0.06%
41,057
-56,153
-58% -$3.37M
BLUE
311
DELISTED
bluebird bio
BLUE
$2.37M 0.06%
2,702
-695
-20% -$503K
EW icon
312
Edwards Lifesciences
EW
$47.6B
$2.36M 0.06%
58,719
-9,837
-14% -$370K
TEVA icon
313
Teva Pharmaceuticals
TEVA
$35.9B
$2.35M 0.06%
51,133
-8,066
-14% -$421K
BNY
314
Bank of New York Mellon
BNY
$108B
$2.34M 0.06%
58,754
-89,752
-60% -$3.58M
QRVO icon
315
Qorvo
QRVO
$7.63B
$2.34M 0.06%
42,041
-138,770
-77% -$7.87M
CAH icon
316
Cardinal Health
CAH
$53.4B
$2.32M 0.06%
29,867
-2,623
-8% -$212K
CNQ icon
317
Canadian Natural Resources
CNQ
$96.9B
$2.32M 0.06%
148,411
-104
-0.1% -$1.58K
SYY icon
318
Sysco
SYY
$39.7B
$2.3M 0.06%
46,919
+5,516
+13% +$283K
GHDX
319
DELISTED
Genomic Health, Inc.
GHDX
$2.29M 0.06%
79,000
+16,000
+25% +$446K
BN icon
320
Brookfield
BN
$102B
$2.28M 0.05%
182,267
-865,184
-83% -$10.6M
RRC icon
321
Range Resources
RRC
$9.11B
$2.27M 0.05%
58,604
+12,125
+26% +$490K
MZOR
322
DELISTED
Mazor Robotics Ltd.
MZOR
$2.26M 0.05%
87,500
+27,500
+46% +$610K
SPGI icon
323
S&P Global
SPGI
$126B
$2.24M 0.05%
17,690
+2,570
+17% +$309K
BDX icon
324
Becton Dickinson
BDX
$43.1B
$2.23M 0.05%
12,740
+4,089
+47% +$699K
ISEE
325
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$2.19M 0.05%
47,500
-34,500
-42% -$1.95M
11 12
13
14 15

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q3 2016 Portfolio in Review

As of Q3 2016, Candriam SCA held 702 positions worth $4.16B, up 8.1% from $3.85B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Candriam SCA's Q3 2016 filing shows 49 new, 376 increased, 176 reduced and 46 closed positions. Its largest new stake was Zions Bancorporation: 362,062 shares worth $11.2M. The largest sale was Procter & Gamble, an estimated $26.9M.

By sector, the portfolio is most concentrated in Healthcare at 26% of assets, up from 25% a quarter earlier, followed by Financials and Technology.

  • Candriam SCA's largest Q3 2016 buy was Zions Bancorporation: 362,062 shares worth $11.2M.
  • Candriam SCA added most to Canadian National Railway in Q3 2016, an estimated $30.2M increase.
  • Candriam SCA's biggest Q3 2016 reduction was Procter & Gamble, cutting an estimated $26.9M.
  • Candriam SCA fully exited EMC CORPORATION in Q3 2016, selling an estimated $19.1M.
  • Candriam SCA's ten largest holdings make up 18% of its $4.16B portfolio in Q3 2016.
  • Candriam SCA opened 49 new positions and closed 46 in Q3 2016.
  • Candriam SCA's portfolio value rose 8.1% quarter-over-quarter to $4.16B.

Based on Candriam SCA's 13F filing for Q3 2016, filed 15 Nov 2016.